Medicine and Dentistry
Lung Nodule
100%
Lung Cancer
81%
Lung Cancer Screening
75%
Computer Assisted Tomography
69%
Low Drug Dose
55%
Cancer
55%
COVID-19
43%
Malignant Neoplasm
31%
Emphysema
26%
National Lung Screening Trial
25%
Image Quality
22%
Risk Evaluation
21%
Diagnosis
20%
Screening
18%
Health Care Cost
17%
Disease
16%
Symptom
15%
Cancer Mortality
15%
Cohort Study
14%
Chest Imaging
14%
Patient Care
14%
Computed Tomography Angiography
14%
Incidental Finding
14%
Apoplexy
13%
False Positive Result
12%
Volume CT
12%
Smoking
12%
Neoplasm
12%
Radiology
11%
Systematic Review
10%
Cost-Effectiveness Analysis
10%
Thorax Radiography
9%
Multidetector Computed Tomography
8%
Cancer Diagnosis
8%
Pancreas Adenocarcinoma
8%
Patient Referral
8%
Volumetry
7%
Lymph Node
7%
Liver Metastasis
7%
Emergency Department
7%
Diagnostic Accuracy
7%
Mechanical Heart Valve
7%
Health Assessment
7%
Gallium 68
7%
Neck
7%
Time to Treatment
7%
Radiomics
7%
Coronary Angiography
7%
Pancreas Cancer
7%
Working Memory
7%
Keyphrases
Nodule
29%
Lung Cancer Screening
26%
Emphysema
23%
National Lung Screening Trial
23%
Lung-RADS
21%
Subsolid Nodule
17%
Lung Cancer
17%
Screening CT
15%
Risk of Malignancy
15%
Computed Tomography
15%
Risk Estimation
14%
Lung Cancer Risk
14%
Netherlands
11%
High Risk
8%
Cancer Cases
8%
Lung Function Decline
7%
Pulmonary Nodule Detection
7%
Chest CT Severity Score
7%
Model Observer
7%
Deep Learning
7%
Load-distributing Band
7%
Computed Tomography Images
7%
Thoracoabdominal Injuries
7%
CT Screening
7%
Low Risk
7%
CT Lung Screening
7%
Pulmonary Nodule
7%
Airway Wall Thickening
7%
Risk Spectrum
7%
Smokers
7%
Heavy Smokers
7%
Interobserver Variability
7%
Automatic Detection
7%
Malignancy
7%
Patient Management
7%
Water Environment
7%
Semi-automated Volumetry
7%
Low-dose CT
7%
Model Lung
7%
Computed Tomographic
7%
Upper Quartile
7%
National Comprehensive Cancer Network Guidelines
7%
EFOMP
7%
Subsolid Pulmonary Nodule
7%
Impact on Patients
7%
Wrist Trauma
7%
Monitoring Approach
7%
Randomized Trial
7%
Algorithm Comparison
7%
European Respiratory Society
7%